Cambrooke Therapeutics

About:

Cambrooke Therapeutics recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies.

Website: http://www.cambrooke.com

Twitter/X: CambrookeFoods

Top Investors: Seventure Partners, Galen Partners, Ruffena Capital

Description:

we dedicated exclusively to providing innovative clinical nutrition products. Our products are administered under medical supervision and are intended for patients who require specialized dietary therapies. We are committed to changing the way people, who require clinical nutrition, experience their diet.

Total Funding Amount:

$10.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Ayer, Massachusetts, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)cambrooke.com

Founders:

Lynn Paolella

Number of Employees:

101-250

Last Funding Date:

2016-04-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai